Long-term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance

British Journal of Haematology

Volumn 118, Issue 2, 2002, Pages 545-549

  Bernasconi, Paolo ^a   Cavigliano, Paola Maria ^a   Boni, Marina ^a   Astori, Cesare ^a   Calatroni, Silvia ^a   Giardini, Ilaria ^a   Rocca, Barbara ^a   Caresana, Marilena ^a   Crosetto, Nicola ^a   Lazzarino, Mario ^a   Bernasconi, Carlo ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

13q ; Cytogenetics; FISH; MGUS; MM

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW; CELL ASSAY; CELL PROLIFERATION; CHROMOSOME 13Q; CHROMOSOME IDENTIFICATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; HUMAN CELL; INCIDENCE; INTERPHASE; KARYOTYPE; MALE; METAPHASE; MONITORING; MONOCLONAL IMMUNOGLOBULINEMIA; MONONUCLEAR CELL; MULTIPLE MYELOMA; PATHOGENESIS; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; TIME;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 4; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MALE; METAPHASE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIAS; PROGNOSIS; TRANSLOCATION, GENETIC;

EID: 0036040315     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03651.x     Document Type: Article

References (25)

1. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma
2. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma
3. Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13
4. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance
5. Cytogenetic analysis of 280 patients with multiple myeloma and related disorder: Primary breakpoints and clinical correlations
6. Deletion of the retinoblastoma gene in multiple myeloma
7. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance
8. Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy
9. A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
10. 2 microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy
11. Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy
12. The t(4;14) (p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance
13. Molecular alteration of IL-6R, lck and c-myc genes in transforming monoclonal gammopathies of undetermined significance
14. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma
15. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance
16. 'Benign' monoclonal gammopathy: After 20-35 years of follow-up
17. Smouldering multiple myeloma
18. Monoclonal gammopathies of undetermined significance
19. Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis
20. Immunophenotypic characterization of plasmacells from monoclonal gammopathies of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma
21. Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes
22. Cytogenetic abnormalities correlate with plasma cell labeling index and extent of bone marrow involvement in myeloma
23. Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants
24. Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition
25. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization